ArticleFrontiers in oncology2025

Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer in first-line/second-line setting.

Jian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.